Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
South African Press Association - November 30, 2005
"Not only was the national roll-out of ARV treatment completed by December 2004, but we have exceeded our patient enrolment targets," Health Minister Sheila Tlou said on the eve of World Aids Day.
"In 2001, the government commissioned a study that estimated approximately 110 000 people would be eligible for ARV treatment.
"By September 2005, Botswana had 4 582 children on ARV treatment under the national programme, with a total of 54 378 people receiving treatment via the public and private health-care systems," said Tlou.
"This has resulted in 48% of all eligible ARV candidates in Botswana receiving life-saving ARV treatment."
Tlou said median baseline CD4 counts have doubled from 50 to 100 since the inception of the programme in 2001.
"In addition, with patient follow-ups above 90%, and high adherence and resultant viral loads undetectable at six months for more than 80% of all patients, Botswana has shown that developing countries can successfully distribute ARV therapy in the public health-care system."
Segolame Ramotlhwa, operations manager of the ARV programme "Masa", said there also appears to be a heartening change of attitude among Batswana towards the disease.
"Batswana are finally understanding that, regardless of their HIV status, they have viable options available to them to continue seeking and living fulfilled lives.
"This attitudinal change is certainly reflected in the increased number of people coming forward for HIV testing."
051130
SA051114
Copyright © 2005 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .